Mutual Fund Research

Tata India Pharma & Healthcare Fund-Reg(G)

As on May-06-2021 change fund
16.29  up0.00 (0.01%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2016-20172017-20182018-20192019-20202020-2021
NAV in Rs (as on 31-Mar-2021)9.118.359.098.9314.73
Net Assets(Rs Crores) (as on 31-Mar-2021) 80.88 133.13 179.56 152.64 435.03
Scheme Returns(%)(Absolute)-2.87-9.687.51-2.1967.24
B'mark Returns(%)(Absolute)-4.73-20.438.42-23.4574.66
Category Rank52/5654/6224/7311/7549/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202125.0721.7811.24-2.68
2019-2020-4.661.784.39-2.98
2018-20192.446.80-4.444.15
2017-2018-4.38-6.159.58-6.86
2016-2017-0.321.99-10.176.42
Top 10 holdings
company (%)
Dr. Reddys Laboratories Ltd.15.10 
Sun Pharmaceutical Industries...9.48 
Divis Laboratories Ltd.8.70 
Cipla Ltd.8.62 
Aurobindo Pharma Ltd.7.80 
Alkem Laboratories Ltd.6.07 
Ipca Laboratories Ltd.5.49 
Fortis Healthcare Ltd.4.74 
Apollo Hospitals Enterprise Ltd.4.70 
Procter & Gamble Health Ltd.3.71 

Category

Sector Funds

Launch Date

28-Dec-15

Scheme Benchmark

NA

AUM ( in Cr.)

435.03

portfolio price to book value

6.08

investing style?

Large Growth

fund manager?

Meeta Shetty

inception date (regular plan)

28-Dec-15

expense ratio (regular plan) %

2.63

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs76.63
Hospital & Healthcare Services16.27
Miscellaneous5.11

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015435.0351.3622.6911.50NA9.54
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,260.9957.9726.0216.3717.9021.84
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005618.1356.7722.1512.2414.6219.00
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,563.9557.4921.639.7717.3316.04
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,109.5866.08NANANA35.29
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,213.6360.57NANANA26.30
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,268.9758.57NANANA29.67
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019454.9147.32NANANA37.33
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201964.4344.26NANANA31.14
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.